R&D Systems™ Recombinant Mouse IGSF9 Protein

Catalog No.	Quantity
91-40S-9050	50 μg

Catalog No. 91-40S-9050 Supplier R&D Systems™ Supplier No. 9140S9050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Mouse IGSF9 Protein is derived from NS0. The Recombinant Mouse IGSF9 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q05BQ1
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 57549
• Molecular Weight (g/mol): Observed M.W.: 95-110kDa, reducing conditions, Theoretical M.W.: 78kDa
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived mouse IGSF9 protein Arg21-Leu730,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: Dasm1, FP18798, IGSF9A, immunoglobulin superfamily member 9A, immunoglobulin superfamily, member 9, KIAA1355, Nrt1, Protein Turtle Homolog A, TUTLA
• Common Name: IGSF9
• Biological Activity: Measured by its ability to inhibit neurite outgrowth of dissociated E13 chick embryonic dorsal root ganglia (DRG) neurons. Able to significantly inhibit neurite outgrowth when immobilized as a 3μL droplet containing 150 ng on a nitrocellulose-coated microplate
• Conjugate: Unconjugated
• Species: Mouse
• Recombinant: Recombinant
• Expression System: Mouse myeloma cell line, NS0-derived Arg21-Leu730, with a C-terminal 6-His tag
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining